Duke University — Durham, North Carolina

Public research footprint of Duke University, compiled from the ClinicalTrials.gov public registry.

5,219

Registered studies

1,215

Active

630

Recruiting now

3,086

Completed

790

Stopped or withdrawn

Most-studied conditions

Acute Myeloid Leukemia · Metastatic Non-Cutaneous Melanoma · Recurrent Non-Cutaneous Melanoma · Malignant Solid Neoplasm

Recently updated registry entries

NCT03712605 — Testing Pembrolizumab Versus Observation in Patients With Merkel Cell Carcinoma After… (Active Not Recruiting)
NCT05675410 — A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs… (Recruiting)
NCT04616560 — Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Duke University?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.